Conditioned effects produced by naltrexone doses that reduce ethanol- reinforced responding in rhesus monkeys

Alcoholism: Clinical and Experimental Research

Volumn 23, Issue 4, 1999, Pages 708-715

  Williams, Keith L ^a,b   Woods, James H ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Alcohol; Conditioned taste aversion; Conditioning; Monkeys; Opioid antagonists

Indexed keywords

ALCOHOL; NALTREXONE; PHENCYCLIDINE; SUCROSE;

ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; CONDITIONED REFLEX; CONTROLLED STUDY; DOSE RESPONSE; DYSPHORIA; MALE; NAUSEA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHESUS MONKEY; TASTE AVERSION;

ALCOHOL DRINKING; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CONDITIONING, CLASSICAL; CONDITIONING, OPERANT; DRINKING BEHAVIOR; ETHANOL; MACACA MULATTA; MALE; NALTREXONE; REWARD; SODIUM CHLORIDE; TASTE;

ANIMALIA; MACACA MULATTA; PRIMATES;

EID: 0032960709     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000374-199904001-00018     Document Type: Article

References (38)

1. Ulm RR, Volpicelli JR, Volpicelli LA: Opiates and alcohol self-administration in animals. J Clin Psychiatry 56:5-14, 1995
2. Kornet M, Goosen C, Van Ree JM: Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology 104:367-376, 1991
3. Myers RD, Borg S, Mossberg R: Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey. Alcohol 3:383-388, 1986
4. Altshuler HL, Phillips PE, Feinhandler DA: Alteration of ethanol self-administration by naltrexone. Life Sci 26:679-688, 1980
5. Williams KL, Winger G, Pakarinen ED, Woods JH: Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys. Psychopharmacology 139:53-61, 1998
6. O'Malley SS, Jaffe AJ, Chang G, Meyer RE, Rounsaville B: Naltrexone and coping skills therapy for alcohol dependence. Arch Gen Psychiatry 49:881-887, 1992
7. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP: Naltrexone in treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880, 1992
8. Holtzman SG: Behavioral effects of separate and combined administration of naloxone and d-amphetamine. J Pharmacol Exp Ther 189: 51-60, 1974
9. Maickel RP, Braude MC, Zabik JE: The effects of various narcotic agonists and antagonists on deprivation-induced fluid consumption. Neuropharmacology 16:863-866, 1977
10. Stapleton JM, Ostrowski NL, Merriman VJ, Lind MD, Reid LD: Naloxone reduces fluid consumption in water-deprived and nondeprived rats. Bull Psychonomic Soc 13:237-239, 1979b
11. Brown DR, Holtzman SG: Narcotic antagonists attenuate drinking induced by water deprivation in a primate. Life Sci 28:1287-1294, 1981
12. Locke KW, Brown DR, Holtzman SG: Effects of opiate antagonist and putative mu- and kappa-agonist on milk intake in rat and squirrel monkey. Pharmacol Biochem Behav 17:1276-1279, 1982
13. Pickar D, Cohen MR, Naber D, Cohen RM: Clinical studies of the endogenous opioid system. Biol Psychiatry 17:1243-1276, 1982
14. Cohen MR, Cohen RM, Pickar D, Weingartner H, Murphy DL: High-dose naloxone infusions in normals. Arch Gen Psychiatry 40:613-619, 1983
15. Mendelson JH, Ellingboe J, Keuhnle JC, Mello NK: Effects of naltrexone on mood and neuroendocrine function in normal adult males. Psychoneuroendocrinology 3:231-236, 1979
16. Crowley TJ, Wagner JE, Zerbe G, Macdonald M: Naltrexone-induced dysphoria in former opioid addicts. Am J Psychiatry 142:1081-1084, 1985
17. Atkinson RL, Berke LK, Drake CR, Bibbs ML, Williams FL, Kaiser DL: Effects of long-term therapy with naltrexone on body weight in obesity. Clin Pharmacol Ther 38:419-422, 1985
18. Malcolm R, O'Neil PM, Sexauer JD, Riddle FE, Currey HS, Counts C: A controlled trial of naltrexone in obese humans. Int J Obesity 9:347-353, 1985
19. Bertino M, Beauchamp GK, Engelman K: Naltrexone, an opioid blocker, alters taste perception and nutrient intake in humans. Am J Physiol 261:R59-R63, 1991
20. Hetherington MM, Vervaet N, Blass E, Rolls BJ: Failure of naltrexone to affect the pleasantness or intake of food. Pharmacol Biochem Behav 40:185-190, 1991
21. Drewnowski A, Krahn DD, Demitrack MA, Nairn K, Gosnell BA: Taste responses and preferences for sweet high-fat foods: Evidence for opioid involvement. Physiol Behav 51:371-379, 1992
22. Deleted in proof.
23. Swift RM, Whelihan W, Kuznetsov O, Buongiorno G, Hsuing H: Naltrexone-induced alterations in human ethanol intoxication. Am J Psychiatry 151:1463-1467, 1994
24. Davidson D, Swift R, Fitz E: Naltrexone increases the latency to drink alcohol in social drinkers. Alcohol Clin Exp Res 20:732-739, 1996
25. King AC, Volpicelli JR, O'Brien CP, Kreek MJ: Naltrexone pretreatment does not alter reduced neuroendocrine response to alcohol in sons of alcoholics. Research Society on Alcoholism Abstracts, Alcohol Clin Exp Res 21(Suppl):32A, 1997
26. Stolerman IP, Pilcher CWT, D'Mello GD: Stereospecific aversive property of narcotic antagonists in morphine-free rats. Life Sci 22:1755-1762, 1978
27. Mucha RF, Herz A: Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology 86:274-280, 1985
28. Mucha RF, Walker MJK: Aversive property of opioid receptor blockade in drug-naive mice. Psychopharmacology 93:483-488, 1987
29. Franchina JJ, Dietz S: Taste aversion following backward conditioning procedures in preweanling and adult rats. Dev Biol 14:499-505, 1981
30. Franchina JJ: Effects of flavor salience on aversion performance following relatively long-delay backward conditioning. Behav Neural Biol 51:127-135, 1989
31. Williams KL, Pakarinen EP, Woods JH: Quadazocine decreases reinforced-responding for oral ethanol, sucrose, and phencyclidine: Comparison to naltrexone effects. Psychopharmacology (in press)
32. Meisch RA, Henningfield JE, Thompson T: Establishment of ethanol as a reinforcer for rhesus monkeys via the oral route: Initial results. Adv Exp Med Biol 59:323-342, 1975
33. Gianoulakis C, de Waele JP: Genetics of alcoholism: Role of endogenous opioid system. Metab Brain Dis 9:105-131, 1994
34. Reid LD: Endogenous opioid peptides and regulation of drinking and feeding. Am J Clin Nutr 42:1099-1132, 1985
35. Winger G, Skjoldager P, Woods JH: Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. J Pharmacol Exp Ther 261: 311-317, 1992
36. Rowlett JK, Wilcox KM, Woolverton WL: Self-administration of cocaine-heroin combinations by rhesus monkeys: Antagonism by naltrexone. J Pharmacol Exp Ther 286:61-69, 1998
37. Ko M-C, Butelman ER, Traynor JR, Woods JH: Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys. J Pharmacol Exp Ther 285:518-526, 1998
38. Schwartz B, Robbins SJ: Psychology of Learning and Behavior. New York, W. W. Norton & Company, 1995